文献速递妇科

子宫内膜上皮内瘤变患者前哨淋巴结活检的使用情况及手术结局

Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia.
PubMed 文献 · Obstet Gynecol · 2024-06-06

基于美国外科医师学会国家手术质量改进计划前瞻性数据库的队列研究,纳入2012至2020年因子宫内膜上皮内瘤变行微创子宫切除术且术后病理确诊的患者4447例,其中586例(13.2%)接受前哨淋巴结活检。前哨淋巴结活检比例从2012年0.6%升至2020年26.1%(P<.001),每年增加16%。前哨淋巴结活检组平均总手术时间较长(139.50±50.34分钟 vs 131.64±55.95分钟,P=.001),静脉血栓栓塞发生率较高(4例[0.7%] vs 4例[0.1%],P=.013),但调整混杂因素后前哨淋巴结活检与任何并发症、主要并发症或次要并发症均无关。

要点

  • 子宫内膜上皮内瘤变患者前哨淋巴结活检比例从2012年0.6%升至2020年26.1%(P<.001)。
  • 前哨淋巴结活检组平均总手术时间较长(139.50±50.34分钟 vs 131.64±55.95分钟,P=.001)。
  • 前哨淋巴结活检组静脉血栓栓塞发生率较高(4例[0.7%] vs 4例[0.1%],P=.013)。

核心结论

  • 子宫内膜上皮内瘤变患者前哨淋巴结活检的使用率正在增加,前哨淋巴结活检与静脉血栓栓塞风险增加相关,手术时间增加可忽略不计。

研究设计与样本

  • 采用美国外科医师学会国家手术质量改进计划前瞻性数据库的队列研究,纳入2012至2020年因子宫内膜上皮内瘤变行微创子宫切除术且术后病理确诊的患者4447例,其中586例(13.2%)接受前哨淋巴结活检。

主要发现

  • 前哨淋巴结活检比例从2012年0.6%升至2020年26.1%(P<.001),每年增加16%。
  • 在多变量回归中纳入年龄、体重指数和手术年份,较近的手术年份与接受前哨淋巴结活检的调整比值比增加独立相关(1.51,95%CI 1.43-1.59)。
  • 前哨淋巴结活检组平均总手术时间较长(139.50±50.34分钟 vs 131.64±55.95分钟,P=.001)。
  • 无前哨淋巴结活检组与前哨淋巴结活检组的任何并发症发生率分别为5.9%与6.7%,主要并发症发生率分别为2.3%与2.4%,次要并发症发生率分别为4.1%与4.9%。
  • 单种并发症分析中,前哨淋巴结活检组静脉血栓栓塞发生率较高(4例[0.7%] vs 4例[0.1%],P=.013)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the rate and surgical outcomes of sentinel lymph node (SLN) biopsy in patients with endometrial intraepithelial neoplasia (EIN). METHODS: We conducted a cohort study that used the prospective American College of Surgeons National Surgical Quality Improvement Program database. Women with EIN on postoperative pathology who underwent minimally invasive hysterectomy from 2012 to 2020 were included. The cohort was dichotomized based on the performance of SLN biopsy. Patients' characteristics, perioperative morbidity, and mortality were compared between patients who underwent SLN biopsy and those who did not. Postoperative complications were defined using the Clavien-Dindo classification system. RESULTS: Overall, 4,447 patients were included; of those, 586 (13.2%) underwent SLN biopsy. The proportion of SLN biopsy has increased steadily from 0.6% in 2012 to 26.1% in 2020 ( P <.001), with a rate of 16% increase per year. In a multivariable regression that included age, body mass index (BMI), and year of surgery, a more recent year of surgery was independently associated with an increased adjusted odds ratio of undergoing SLN biopsy (1.51, 95% CI, 1.43-1.59). The mean total operative time was longer in the SLN biopsy group (139.50±50.34 minutes vs 131.64±55.95 minutes, P =.001). The rate of any complication was 5.9% compared with 6.7%, the rate of major complications was 2.3% compared with 2.4%, and the rate of minor complications was 4.1% compared with 4.9% for no SLN biopsy and SLN biopsy, respectively. In a single complications analysis, the rate of venous thromboembolism was higher in the SLN biopsy group (four [0.7%] vs four [0.1%], P =.013). In a multivariable regression analysis adjusted for age, BMI, American Society of Anesthesiologists classification, uterus weight, and preoperative hematocrit, the performance of SLN biopsy was not associated with any complications, major complications, or minor complications. CONCLUSION: The performance of SLN biopsy in EIN is increasing. Sentinel lymph node biopsy for EIN is associated with an increased risk of venous thromboembolism and a negligible increased surgical time.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Levin G, Wright JD, Burke YZ, et al. Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia. Obstet Gynecol. 2024. PMID: 38843523. doi:10.1097/AOG.0000000000005637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。